Global Fluorescence In Situ Hybridization (FISH) Imaging Systems Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Instruments - [Microscopes, Automated Cell Analyzers and Others], Consumables & Accessories, Services, and Software

By Technology;

DNA FISH, RNA FISH, PNA FISH, and CISH

By Application;

Cancer Diagnosis - [Lung Cancer, Breast Cancer and Others], Genetic Disease Diagnosis, and Others

By End Use;

Diagnostic Laboratories, Research & Academic Institutes, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn999725200 Published Date: May, 2025 Updated Date: June, 2025

Introduction

Global Fluorescence In Situ Hybridization (FISH) Imaging Systems Market (USD Million), 2021 - 2031

Fluorescence In Situ Hybridization (FISH) Imaging Systems Market was valued at USD 5,986.30 million in the year 2024. The size of this market is expected to increase to USD 9,241.66 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.4%.


Global Fluorescence In Situ Hybridization (FISH) Imaging Systems Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 6.4 %


Study Period2025 - 2031
Base Year2024
CAGR (%)6.4 %
Market Size (2024)USD 5,986.30 Million
Market Size (2031)USD 9,241.66 Million
Market ConcentrationMedium
Report Pages363
5,986.30
2024
9,241.66
2031

Major Players

  • Thermo Fisher Scientific Inc
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Agilent Technologies, Inc
  • PerkinElmer, Inc
  • Leica Biosystems Nussloch GmbH
  • Bio-Rad Laboratories, Inc
  • Oxford Gene Technology (OGT)
  • MetaSystems GmbH
  • Applied Spectral Imaging Inc

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Fluorescence In Situ Hybridization (FISH) Imaging Systems Market

Fragmented - Highly competitive market without dominant players


The Fluorescence In Situ Hybridization (FISH) Imaging Systems Market is advancing rapidly, driven by the need for accurate molecular diagnostics in medical research and clinical practice. FISH imaging provides essential insights into chromosomal changes, supporting early disease detection. Adoption of these systems has increased by over 40%, as laboratories seek efficient tools for genetic and cancer diagnostics.

Growth Catalysts
Key contributors to market expansion include the rising incidence of cancer and genetic abnormalities, along with technological integration like AI-powered imaging. These innovations have improved diagnostic precision by more than 30%. The growing utilization of FISH in fertility and rare disease diagnostics has also elevated demand, contributing to broader system deployment across laboratories.

Technology Trends
The market is witnessing a shift towards advanced multiplex imaging systems with enhanced detection capabilities, boosting diagnostic accuracy by over 25%. The emergence of digital pathology solutions and remote-access platforms has simplified workflows and supported rapid result interpretation. Such progress continues to reinforce the clinical relevance of FISH technologies.

Market Prospects
Continued investments in genomic research and personalized medicine are set to boost the adoption of FISH systems further. Innovations in probe design and hybridization efficiency are expected to increase sensitivity by over 35%. As clinical needs evolve, the role of FISH in oncology, pharmacogenomics, and prenatal diagnostics is poised to expand substantially.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Technology
    3. Market Snapshot, By Application
    4. Market Snapshot, By End Use
    5. Market Snapshot, By Region
  4. Global Fluorescence In Situ Hybridization (FISH) Imaging Systems Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Growing demand for molecular diagnostics
        2. Technological advancements in imaging systems
        3. Increasing applications in cancer research
      2. Restraints
        1. High cost of fluorescence imaging systems
        2. Stringent regulatory requirements
        3. Limited accessibility in developing regions
      3. Opportunities
        1. Expansion in emerging markets
        2. Development of automated FISH systems
        3. Integration with other diagnostic techniques
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Fluorescence In Situ Hybridization (FISH) Imaging Systems Market, By Product, 2021 - 2031 (USD Million)
      1. Instruments
        1. Microscopes
        2. Automated Cell Analyzers
        3. Others
      2. Consumables & Accessories
      3. Services
      4. Software
    2. Global Fluorescence In Situ Hybridization (FISH) Imaging Systems Market, By Technology, 2021 - 2031 (USD Million)

      1. DNA FISH

      2. RNA FISH

      3. PNA FISH

      4. CISH

    3. Global Fluorescence In Situ Hybridization (FISH) Imaging Systems Market, By Application, 2021 - 2031 (USD Million)
      1. Cancer Diagnosis
        1. Lung Cancer
        2. Breast Cancer
        3. Others
      2. Genetic Disease Diagnosis
      3. Others
    4. Global Fluorescence In Situ Hybridization (FISH) Imaging Systems Market, By End Use, 2021 - 2031 (USD Million)
      1. Diagnostic Laboratories
      2. Research & Academic Institutes
      3. Others
    5. Global Fluorescence In Situ Hybridization (FISH) Imaging Systems Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Thermo Fisher Scientific Inc
      2. Abbott Laboratories
      3. F. Hoffmann-La Roche Ltd
      4. Agilent Technologies, Inc
      5. PerkinElmer, Inc
      6. Leica Biosystems Nussloch GmbH
      7. Bio-Rad Laboratories, Inc
      8. Oxford Gene Technology (OGT)
      9. MetaSystems GmbH
      10. Applied Spectral Imaging Inc
  7. Analyst Views
  8. Future Outlook of the Market